Cite
MLA Citation
Xavier Armoiry et al.. “Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myeloma.” Journal of market access & health policy, vol. 7, no. 1, 2019, p. . http://access.bl.uk/ark:/81055/vdc_100099961678.0x000024